We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Microarray Analysis of Gene Expression in Liver Tumors

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00373737
First Posted: September 8, 2006
Last Update Posted: July 27, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institutes of Health (NIH)
Information provided by:
Stanford University
September 6, 2006
September 8, 2006
July 27, 2010
May 1999
April 2008   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00373737 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Microarray Analysis of Gene Expression in Liver Tumors
Microarray Analysis of Gene Expression in Liver Tumors
This study aims to study the gene expression profiles of liver tumors to help us understand their biology, and to find new tumor and treatment markers for liver cancer.
The purpose of this research is to study of the biologic features of liver tissue (by studying their gene expression profiles), so that we can increase our understanding of the processes involved in liver cancer development and growth. This may allow us to identify more effective ways of diagnosing, treating, and predicting the outcome of patients with liver cancer.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
liver tumor
Non-Probability Sample
Patients with liver tumors undergoing partial liver resection, open liver biopsy, and patients undergoing liver transplantation with or without liver tumors at Stanford University
Liver Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
300
December 2008
April 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:Inclusion Criteria:

  • Patients with liver tumors undergoing partial liver resection, open liver biopsy, and patients undergoing liver transplantation with or without liver tumors at Stanford University
  • Patients older than 18
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00373737
HEP0005
76710
HEP0005
Not Provided
Not Provided
Not Provided
Samuel So, Stanford University School of Medicine
Stanford University
National Institutes of Health (NIH)
Principal Investigator: Samuel So Stanford University
Stanford University
July 2010